|
6 March 2014 |
("AMS" or the the "Company")
Winsford, UK:Advanced Medical Solutions Group plc (AIM:AMS), the global medical technology company, today announces that Chris Meredith, Chief Executive Officer, has today sold a total of 643,250 ordinary shares of 5p each ("Ordinary Shares") at 114 pence per share. These shares come from a combination of the exercise of certain share incentive schemes and existing Ordinary Shares. Separately, Mr Meredith's SIPP has today acquired 87,719 Ordinary Shares at 114 pence per share.
As a result of these transactions, Mr Meredith's beneficial interest in Ordinary Shares has increased from 1,142,275 to 1,182,938.
A summary of Mr Meredith's beneficial interest in Ordinary Shares and Ordinary Shares under incentive schemes is summarised in the table below.
|
Number prior to transaction |
Number exercised |
Shares sold |
SIPP purchase |
Resultant interest |
Ordinary Shares |
1,142,275 |
- |
47,056 |
87,719 |
1,182,938 |
Long Term Incentive Plan |
1,309,293 |
514,778 |
514,778 |
- |
794,515 |
Deferred Share Bonus Plan |
99,325 |
81,416 |
81,416 |
- |
17,909 |
- End -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group plc |
Tel: +44 (0) 1606 545508 |
Mary Tavener, Group Finance Director |
|
|
|
Investec Bank PLC (NOMAD & Broker) |
Tel: +44 (0) 20 7597 5970 |
Daniel Adams |
|